001     179297
005     20240229145539.0
024 7 _ |a 10.1080/15548627.2022.2052588
|2 doi
024 7 _ |a pmid:35343375
|2 pmid
024 7 _ |a 1554-8627
|2 ISSN
024 7 _ |a 1554-8635
|2 ISSN
024 7 _ |a altmetric:125493458
|2 altmetric
037 _ _ |a DKFZ-2022-00579
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Mainz, Laura
|b 0
245 _ _ |a Acute systemic knockdown of Atg7 is lethal and causes pancreatic destruction in shRNA transgenic mice.
260 _ _ |a Abingdon, Oxon
|c 2022
|b Taylor & Francis
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1668695344_22118
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Dec;18(12):2880-2893
520 _ _ |a The notion that macroautophagy/autophagy is a potentially attractive therapeutic target for a variety of diseases, including cancer, largely stems from pre-clinical mouse studies. Most of these examine the effects of irreversible and organ confined autophagy deletion using site specific Cre-loxP recombination of the essential autophagy regulating genes Atg7 or Atg5. Model systems with the ability to impair autophagy systemically and reversibly at all disease stages would allow a more realistic approach to evaluate the consequences of authophagy inhibition as a therapeutic concept and its potential side effects. Here, we present shRNA transgenic mice that via doxycycline (DOX) regulable expression of a highly efficient miR30-E-based shRNA enabled knockdown of Atg7 simultaneously in the majority of organs, with the brain and spleen being noteable exceptions. Induced animals deteriorated rapidly and experienced profound destruction of the exocrine pancreas, severe hypoglycemia and depletion of hepatic glycogen storages. Cessation of DOX application restored apparent health, glucose homeostasis and pancreatic integrity. In a similar Atg5 knockdown model we neither observed loss of pancreatic integrity nor diminished survival after DOX treatment, but identified histological changes consistent with steatohepatitis and hepatic fibrosis in the recovery period after termination of DOX. Regulable Atg7-shRNA mice are valuable tools that will enable further studies on the role of autophagy impairment at various disease stages and thereby help to evaluate the consequences of acute autophagy inhibition as a therapeutic concept.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Atg5
|2 Other
650 _ 7 |a Atg7
|2 Other
650 _ 7 |a autophagy
|2 Other
650 _ 7 |a liver
|2 Other
650 _ 7 |a pancreas
|2 Other
650 _ 7 |a shRNA transgenic mice
|2 Other
700 1 _ |a Sarhan, Mohamed A F E
|b 1
700 1 _ |a Roth, Sabine
|b 2
700 1 _ |a Sauer, Ursula
|b 3
700 1 _ |a Kalogirou, Charis
|b 4
700 1 _ |a Eckstein, Markus
|b 5
700 1 _ |a Gerhard-Hartmann, Elena
|b 6
700 1 _ |a Seibert, Helen-Desiree
|b 7
700 1 _ |a Voelker, Hans-Ulrich
|0 0000-0003-0610-2254
|b 8
700 1 _ |a Geppert, Carol
|b 9
700 1 _ |a Rosenwald, Andreas
|b 10
700 1 _ |a Eilers, Martin
|b 11
700 1 _ |a Schulze, Almut
|0 P:(DE-He78)94ae391f53fb9285e1b68f9930615af1
|b 12
|u dkfz
700 1 _ |a Diefenbacher, Markus
|b 13
700 1 _ |a Rosenfeldt, Mathias T
|0 0000-0001-7650-8458
|b 14
773 _ _ |a 10.1080/15548627.2022.2052588
|g p. 1 - 14
|0 PERI:(DE-600)2262043-6
|n 12
|p 2880-2893
|t Autophagy
|v 18
|y 2022
|x 1554-8627
909 C O |p VDB
|o oai:inrepo02.dkfz.de:179297
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)94ae391f53fb9285e1b68f9930615af1
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-18
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AUTOPHAGY : 2021
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-18
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-18
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b AUTOPHAGY : 2021
|d 2022-11-18
920 1 _ |0 I:(DE-He78)A410-20160331
|k A410
|l Metabolismus und Microenvironment
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A410-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21